Target intelligence / Profile preview

RNA, U7 small nuclear 53 pseudogene (RNU7-53P)

Target
RNU7-53P
Molecular classification
Pseudogene, Small nuclear RNA (snRNA), Non-coding RNA
01

Overview

RNA, U7 small nuclear 53 pseudogene (RNU7-53P) is classified as a pseudogene of U7 small nuclear RNA, not an active receptor, enzyme, or therapeutic target[1]. Pseudogenes are DNA sequences similar to normal genes but generally nonfunctional, usually resulting from gene duplication or retrotransposition events. The functional form, U7 small nuclear RNA (U7 snRNA), is an essential component of the U7 small nuclear ribonucleoprotein (snRNP), which is involved in the 3' end processing of replication-dependent histone pre-mRNA in eukaryotic cells[5][3]. The functional U7 snRNA, encoded by other genes such as RNU7-1, is critical for proper histone mRNA maturation, DNA replication, and cell division[2][4]. However, the RNU7-53P pseudogene does not produce functional RNA or protein and does not participate in any known biological, disease, or therapeutic processes[1]. Key points: - RNU7-53P is **not an active gene, receptor, or druggable target**; it is a non-functional pseudogene[1]. - It has **no known molecular, biological, or pathological functions**. - No interacting drugs, mechanisms of action, biomarkers, or safety concerns are associated with this pseudogene. - The functional equivalent, U7 snRNA (from RNU7-1), plays an essential cellular role, but **RNU7-53P does not**. This target is **incorrect for drug or therapeutic consideration** due to its pseudogene classification and lack of function[1].

Other names
U7.53RNU7-53PU7.53 pseudogene

Beyond the preview

Go deeper on RNA, U7 small nuclear 53 pseudogene (RNU7-53P).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on RNA, U7 small nuclear 53 pseudogene (RNU7-53P).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call